Global Cancer Gene Testing Service Supply, Demand and Key Producers, 2023-2029

March 2023 | 110 pages | ID: G27B0A22EF33EN
GlobalInfoResearch

Abstracts

The global Cancer Gene Testing Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cancer Gene Testing Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Gene Testing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Gene Testing Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cancer Gene Testing Service total market, 2018-2029, (USD Million)

Global Cancer Gene Testing Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cancer Gene Testing Service total market, key domestic companies and share, (USD Million)

Global Cancer Gene Testing Service revenue by player and market share 2018-2023, (USD Million)

Global Cancer Gene Testing Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Cancer Gene Testing Service total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Cancer Gene Testing Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience and Sophia Genetics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Gene Testing Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cancer Gene Testing Service Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Cancer Gene Testing Service Market, Segmentation by Type

• Breast Cancer Risk Genetic Testing
• Stomach Cancer Risk Gene Testing
• Rectal Cancer Risk Genetic Testing
• Others

Global Cancer Gene Testing Service Market, Segmentation by Application

• Hospital
• Clinic

Companies Profiled:

• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• CooperSurgical, Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Twist Bioscience
• Sophia Genetics
• Fulgent Genetic, Inc.

Key Questions Answered

1. How big is the global Cancer Gene Testing Service market?

2. What is the demand of the global Cancer Gene Testing Service market?

3. What is the year over year growth of the global Cancer Gene Testing Service market?

4. What is the total value of the global Cancer Gene Testing Service market?

5. Who are the major players in the global Cancer Gene Testing Service market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Cancer Gene Testing Service Introduction
1.2 World Cancer Gene Testing Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cancer Gene Testing Service Total Market by Region (by Headquarter Location)
  1.3.1 World Cancer Gene Testing Service Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Cancer Gene Testing Service Market Size (2018-2029)
  1.3.3 China Cancer Gene Testing Service Market Size (2018-2029)
  1.3.4 Europe Cancer Gene Testing Service Market Size (2018-2029)
  1.3.5 Japan Cancer Gene Testing Service Market Size (2018-2029)
  1.3.6 South Korea Cancer Gene Testing Service Market Size (2018-2029)
  1.3.7 ASEAN Cancer Gene Testing Service Market Size (2018-2029)
  1.3.8 India Cancer Gene Testing Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Cancer Gene Testing Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Cancer Gene Testing Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Cancer Gene Testing Service Consumption Value (2018-2029)
2.2 World Cancer Gene Testing Service Consumption Value by Region
  2.2.1 World Cancer Gene Testing Service Consumption Value by Region (2018-2023)
  2.2.2 World Cancer Gene Testing Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Cancer Gene Testing Service Consumption Value (2018-2029)
2.4 China Cancer Gene Testing Service Consumption Value (2018-2029)
2.5 Europe Cancer Gene Testing Service Consumption Value (2018-2029)
2.6 Japan Cancer Gene Testing Service Consumption Value (2018-2029)
2.7 South Korea Cancer Gene Testing Service Consumption Value (2018-2029)
2.8 ASEAN Cancer Gene Testing Service Consumption Value (2018-2029)
2.9 India Cancer Gene Testing Service Consumption Value (2018-2029)

3 WORLD CANCER GENE TESTING SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World Cancer Gene Testing Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Cancer Gene Testing Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Cancer Gene Testing Service in 2022
  3.2.3 Global Concentration Ratios (CR8) for Cancer Gene Testing Service in 2022
3.3 Cancer Gene Testing Service Company Evaluation Quadrant
3.4 Cancer Gene Testing Service Market: Overall Company Footprint Analysis
  3.4.1 Cancer Gene Testing Service Market: Region Footprint
  3.4.2 Cancer Gene Testing Service Market: Company Product Type Footprint
  3.4.3 Cancer Gene Testing Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Cancer Gene Testing Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Cancer Gene Testing Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Cancer Gene Testing Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cancer Gene Testing Service Consumption Value Comparison
  4.2.1 United States VS China: Cancer Gene Testing Service Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Cancer Gene Testing Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cancer Gene Testing Service Companies and Market Share, 2018-2023
  4.3.1 United States Based Cancer Gene Testing Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Cancer Gene Testing Service Revenue, (2018-2023)
4.4 China Based Companies Cancer Gene Testing Service Revenue and Market Share, 2018-2023
  4.4.1 China Based Cancer Gene Testing Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Cancer Gene Testing Service Revenue, (2018-2023)
4.5 Rest of World Based Cancer Gene Testing Service Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Cancer Gene Testing Service Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Cancer Gene Testing Service Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Cancer Gene Testing Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Breast Cancer Risk Genetic Testing
  5.2.2 Stomach Cancer Risk Gene Testing
  5.2.3 Rectal Cancer Risk Genetic Testing
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World Cancer Gene Testing Service Market Size by Type (2018-2023)
  5.3.2 World Cancer Gene Testing Service Market Size by Type (2024-2029)
  5.3.3 World Cancer Gene Testing Service Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Cancer Gene Testing Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
6.3 Market Segment by Application
  6.3.1 World Cancer Gene Testing Service Market Size by Application (2018-2023)
  6.3.2 World Cancer Gene Testing Service Market Size by Application (2024-2029)
  6.3.3 World Cancer Gene Testing Service Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Natera, Inc.
  7.1.1 Natera, Inc. Details
  7.1.2 Natera, Inc. Major Business
  7.1.3 Natera, Inc. Cancer Gene Testing Service Product and Services
  7.1.4 Natera, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Natera, Inc. Recent Developments/Updates
  7.1.6 Natera, Inc. Competitive Strengths & Weaknesses
7.2 Laboratory Corporation of America Holdings
  7.2.1 Laboratory Corporation of America Holdings Details
  7.2.2 Laboratory Corporation of America Holdings Major Business
  7.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Product and Services
  7.2.4 Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Laboratory Corporation of America Holdings Recent Developments/Updates
  7.2.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.3 F. Hoffmann-La Roche Ltd
  7.3.1 F. Hoffmann-La Roche Ltd Details
  7.3.2 F. Hoffmann-La Roche Ltd Major Business
  7.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product and Services
  7.3.4 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
  7.3.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.4 Quest Diagnostics Incorporated
  7.4.1 Quest Diagnostics Incorporated Details
  7.4.2 Quest Diagnostics Incorporated Major Business
  7.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Product and Services
  7.4.4 Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Quest Diagnostics Incorporated Recent Developments/Updates
  7.4.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
7.5 CooperSurgical, Inc.
  7.5.1 CooperSurgical, Inc. Details
  7.5.2 CooperSurgical, Inc. Major Business
  7.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Product and Services
  7.5.4 CooperSurgical, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 CooperSurgical, Inc. Recent Developments/Updates
  7.5.6 CooperSurgical, Inc. Competitive Strengths & Weaknesses
7.6 Agilent Technologies, Inc.
  7.6.1 Agilent Technologies, Inc. Details
  7.6.2 Agilent Technologies, Inc. Major Business
  7.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Product and Services
  7.6.4 Agilent Technologies, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Agilent Technologies, Inc. Recent Developments/Updates
  7.6.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.7 Thermo Fisher Scientific, Inc.
  7.7.1 Thermo Fisher Scientific, Inc. Details
  7.7.2 Thermo Fisher Scientific, Inc. Major Business
  7.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product and Services
  7.7.4 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
  7.7.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.8 Twist Bioscience
  7.8.1 Twist Bioscience Details
  7.8.2 Twist Bioscience Major Business
  7.8.3 Twist Bioscience Cancer Gene Testing Service Product and Services
  7.8.4 Twist Bioscience Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Twist Bioscience Recent Developments/Updates
  7.8.6 Twist Bioscience Competitive Strengths & Weaknesses
7.9 Sophia Genetics
  7.9.1 Sophia Genetics Details
  7.9.2 Sophia Genetics Major Business
  7.9.3 Sophia Genetics Cancer Gene Testing Service Product and Services
  7.9.4 Sophia Genetics Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Sophia Genetics Recent Developments/Updates
  7.9.6 Sophia Genetics Competitive Strengths & Weaknesses
7.10 Fulgent Genetic, Inc.
  7.10.1 Fulgent Genetic, Inc. Details
  7.10.2 Fulgent Genetic, Inc. Major Business
  7.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Product and Services
  7.10.4 Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Fulgent Genetic, Inc. Recent Developments/Updates
  7.10.6 Fulgent Genetic, Inc. Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Cancer Gene Testing Service Industry Chain
8.2 Cancer Gene Testing Service Upstream Analysis
8.3 Cancer Gene Testing Service Midstream Analysis
8.4 Cancer Gene Testing Service Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Cancer Gene Testing Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cancer Gene Testing Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cancer Gene Testing Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cancer Gene Testing Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cancer Gene Testing Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cancer Gene Testing Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cancer Gene Testing Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cancer Gene Testing Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cancer Gene Testing Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cancer Gene Testing Service Players in 2022
Table 12. World Cancer Gene Testing Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cancer Gene Testing Service Company Evaluation Quadrant
Table 14. Head Office of Key Cancer Gene Testing Service Player
Table 15. Cancer Gene Testing Service Market: Company Product Type Footprint
Table 16. Cancer Gene Testing Service Market: Company Product Application Footprint
Table 17. Cancer Gene Testing Service Mergers & Acquisitions Activity
Table 18. United States VS China Cancer Gene Testing Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cancer Gene Testing Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cancer Gene Testing Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cancer Gene Testing Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cancer Gene Testing Service Revenue Market Share (2018-2023)
Table 23. China Based Cancer Gene Testing Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cancer Gene Testing Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cancer Gene Testing Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cancer Gene Testing Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cancer Gene Testing Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cancer Gene Testing Service Revenue Market Share (2018-2023)
Table 29. World Cancer Gene Testing Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cancer Gene Testing Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cancer Gene Testing Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cancer Gene Testing Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cancer Gene Testing Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cancer Gene Testing Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Natera, Inc. Basic Information, Area Served and Competitors
Table 36. Natera, Inc. Major Business
Table 37. Natera, Inc. Cancer Gene Testing Service Product and Services
Table 38. Natera, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Natera, Inc. Recent Developments/Updates
Table 40. Natera, Inc. Competitive Strengths & Weaknesses
Table 41. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
Table 42. Laboratory Corporation of America Holdings Major Business
Table 43. Laboratory Corporation of America Holdings Cancer Gene Testing Service Product and Services
Table 44. Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 46. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 47. F. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 48. F. Hoffmann-La Roche Ltd Major Business
Table 49. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product and Services
Table 50. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 52. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Incorporated Basic Information, Area Served and Competitors
Table 54. Quest Diagnostics Incorporated Major Business
Table 55. Quest Diagnostics Incorporated Cancer Gene Testing Service Product and Services
Table 56. Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Quest Diagnostics Incorporated Recent Developments/Updates
Table 58. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
Table 59. CooperSurgical, Inc. Basic Information, Area Served and Competitors
Table 60. CooperSurgical, Inc. Major Business
Table 61. CooperSurgical, Inc. Cancer Gene Testing Service Product and Services
Table 62. CooperSurgical, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. CooperSurgical, Inc. Recent Developments/Updates
Table 64. CooperSurgical, Inc. Competitive Strengths & Weaknesses
Table 65. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 66. Agilent Technologies, Inc. Major Business
Table 67. Agilent Technologies, Inc. Cancer Gene Testing Service Product and Services
Table 68. Agilent Technologies, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Agilent Technologies, Inc. Recent Developments/Updates
Table 70. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 72. Thermo Fisher Scientific, Inc. Major Business
Table 73. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product and Services
Table 74. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 76. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
Table 77. Twist Bioscience Basic Information, Area Served and Competitors
Table 78. Twist Bioscience Major Business
Table 79. Twist Bioscience Cancer Gene Testing Service Product and Services
Table 80. Twist Bioscience Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Twist Bioscience Recent Developments/Updates
Table 82. Twist Bioscience Competitive Strengths & Weaknesses
Table 83. Sophia Genetics Basic Information, Area Served and Competitors
Table 84. Sophia Genetics Major Business
Table 85. Sophia Genetics Cancer Gene Testing Service Product and Services
Table 86. Sophia Genetics Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sophia Genetics Recent Developments/Updates
Table 88. Fulgent Genetic, Inc. Basic Information, Area Served and Competitors
Table 89. Fulgent Genetic, Inc. Major Business
Table 90. Fulgent Genetic, Inc. Cancer Gene Testing Service Product and Services
Table 91. Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Cancer Gene Testing Service Upstream (Raw Materials)
Table 93. Cancer Gene Testing Service Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Gene Testing Service Picture
Figure 2. World Cancer Gene Testing Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Gene Testing Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cancer Gene Testing Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cancer Gene Testing Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cancer Gene Testing Service Revenue (2018-2029) & (USD Million)
Figure 13. Cancer Gene Testing Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cancer Gene Testing Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cancer Gene Testing Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cancer Gene Testing Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Gene Testing Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Gene Testing Service Markets in 2022
Figure 27. United States VS China: Cancer Gene Testing Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Gene Testing Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cancer Gene Testing Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cancer Gene Testing Service Market Size Market Share by Type in 2022
Figure 31. Breast Cancer Risk Genetic Testing
Figure 32. Stomach Cancer Risk Gene Testing
Figure 33. Rectal Cancer Risk Genetic Testing
Figure 34. Others
Figure 35. World Cancer Gene Testing Service Market Size Market Share by Type (2018-2029)
Figure 36. World Cancer Gene Testing Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Cancer Gene Testing Service Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Clinic
Figure 40. Cancer Gene Testing Service Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source